REFERENCES
1. Liu X, Zhang Y, Zhou S, Dain L, Mei L, Zhu G. Circular RNA: an emerging frontier in RNA therapeutic targets, RNA therapeutics, and mRNA vaccines. J Controlled Release. 2022;348:84-94.
2. Hashemi M, Khosroshahi EM, Daneii P, et al. Emerging roles of CircRNA-miRNA networks in cancer development and therapeutic response. Noncoding RNA Res. 2025;10:98-115.
3. Chen L. The expanding regulatory mechanisms and cellular functions of circular RNAs. Nat Rev Mol Cell Biol. 2020;21:475-90.
4. Li H, Wang S, Dai F, et al. m6A-dependent translation of circPICALM encodes a novel metastasis-promoting oncoprotein in intrahepatic cholangiocarcinoma. Mol Cancer. 2026;25:96.
5. Alvaro D, Gores GJ, Walicki J, et al. EASL-ILCA Clinical Practice Guidelines on the management of intrahepatic cholangiocarcinoma. J Hepatol. 2023;79:181-208.
6. Yu H, Pardoll D, Jove R. STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer. 2009;9:798-809.
7. Zhang W, Xu C, Yang Z, et al. Circular RNAs in tumor immunity and immunotherapy. Mol Cancer. 2024;23:171.




